首页> 外国专利> Use of polyclonal antibodies against clostridium difficile for treatment of inflammatory bowel disease

Use of polyclonal antibodies against clostridium difficile for treatment of inflammatory bowel disease

机译:抗艰难梭菌多克隆抗体在治疗炎症性肠病中的应用

摘要

The present invention provides a polyclonal antibody composition prepared from eggs of hens immunized with virulent antigens of Clostridium difficile for use in the treatment and prevention of C. difficile infections in subjects with Inflammatory Bowel Disease including Ulcerative colitis and Crohn's disease. Respective groups of hens are immunized with Toxin A or Toxin B of Clostridium difficile or a Clostridium difficile spore preparation. The polyclonal antibodies are recovered from eggs pooled from the immunized hens and the resulting antibody-egg powder is administered orally in a therapeutically effective amount to individuals infected with or suspected of being infected with C. difficile.
机译:本发明提供了由用艰难梭菌的强力抗原免疫的母鸡的卵制备的多克隆抗体组合物,其用于治疗和预防 C。患有炎症性肠病(包括溃疡性结肠炎和克罗恩氏病)的患者的艰难梭菌感染。用艰难梭菌艰难梭菌孢子制剂的毒素A或毒素B免疫各组母鸡。从免疫母鸡收集的卵中回收多克隆抗体,并将所得的抗体-鸡蛋粉末以治疗有效量经口服给予感染或怀疑感染I C的个体。难。

著录项

  • 公开/公告号US10513552B2

    专利类型

  • 公开/公告日2019-12-24

    原文格式PDF

  • 申请/专利权人 IMMUNIMED INC.;

    申请/专利号US201715845214

  • 发明设计人 PRADIP K. MAITI;

    申请日2017-12-18

  • 分类号C07K16/02;A61K9;C07K16/40;A61K39;A61P1;C07K16/12;A61P31/04;

  • 国家 US

  • 入库时间 2022-08-21 11:28:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号